LINC 2018, the Leipzig Interventional Course, will feature state-of-the-art lectures and numerous live cases performed from leading interventional centers.
LINC 2018 took place from Tuesday, January 30 through Friday, February 2, 2018.
Cookie notice
In order to use the Issuu PDF reader, you will have to consent to the use of cookies categorized under "External Services".
TOPICS TO BE DISCUSSED: How do you foresee the real role of the sac-filling concept?
TOPICS TO BE DISCUSSED: The post-implant syndrome: is it a real concern to be avoided?
TOPICS TO BE DISCUSSED: What will be the best endovascular solution for the arch pathology?
TOPICS TO BE DISCUSSEN: Are new adjuvants needed for acute and chronic Type B dissection management
Wednesday, January 31st:
-
,
Room 4 - Discussion Forum
VIVA@LINC: Strategies on the frontline – The year in review: My worst complication of 2017
Moderator:
PeterSchneider
Discussant:
EhrinArmstrong,
GaryAnsel
Aortic
PeterSchneider
Carotid
EhrinArmstrong
Lower extremity
GaryAnsel
Venous
DanielaBranzan
This is a case-based session focusing on what we like best ... real cases with challenges and complications that make the experts sweat. In this amphitheater setting, audience participation is encouraged and step-by-step case management is featured and discussed. This round room setting is dedicated to controversial or interactive talk-show-like sessions.
Wednesday, January 31st:
-
,
Room 4 - Discussion Forum
Lunch symposium: Drug-coated balloons for peripheral interventions: a 360° virtual reality experience
supported with an educational grant from
Cardionovum
Moderator:
PeterGoverde,
DierkScheinert
-
Introduction
-
SAFEPAX®: What’s new in the 3rd generation paclitaxel balloon matrix coating?
EricDucasse
-
How can we improve treatment of long femoropopliteal lesions with DCB?
MarcBosiers
-
Recorded case presentation: let’s do it together: experience the future of “medicine in virtual reality”
EnricoMarone
-
Recorded case presentation: how can we protect the (CLI) patients to the potential risk of microembolisation?
KoenDeloose
-
Conclusions and closing remarks
Wednesday, January 31st:
-
,
Room 4 - Discussion Forum
Experience the treatment journey of complex cases with innovative vascular solution – Case studies across the spectrum of vascular care
supported with an educational grant from
Gore & Associates
Moderator:
MichelMakaroun
Treatment of complex thoracic cases
ChristophNienaber
Clinical implications of the aortic arch and thoracic curvature remodeling after TEVAR
VicenteRiambau
Preserving the hypogastric artery: why, when, and how
GiovanniPratesi
Wednesday, January 31st:
-
,
Room 4 - Discussion Forum
CICE@LINC: The role of mechanical thrombectomy in arterial and venous obstructions
Moderator:
ArmandoLobato
Venous thrombectomy: greater effectiveness with lower risk!
Luiz AntonioFuruya
Hemodialysis vascular access salvage with mechanical debulking device
CristinaRiguetti-Pinto
Mechanical debulking – Is it effective in endograft iliac limb occlusion?
Guilherme VieiraMeirelles
Mechanical thrombectomy in peripheral interventions: A multitask and effective tool in a widening scenario. Current evidence and technical tips.
BrunoFreitas
Acute and subacute ischemia of the lower limb – Can mechanical debulking replace surgery and thrombolyses?
MiroslavBulvas
Thursday, February 1st:
-
,
Room 4 - Discussion Forum
Advanced EVAR therapy with Heli-FX EndoAnchors
sponsored by
Medtronic
Moderator:
GiovanniTorsello
-
Introduction
-
New indication for Heli-FX EndoAnchors with Endurant II: further option in treatment of hostile necks
SvenSeifert
-
EVAR revision setting: how can Heli-FX EndoAnchors improve the outcomes?
DittmarBöckler
-
Heli-FX EndoAnchors in the thoracoabdominal aorta
JörgTeßarek
-
Heli-FX EndoAnchors during TEVAR: indications and outcomes
PiotrKasprzak
-
Discussion and conclusion
Thursday, February 1st:
-
,
Room 4 - Discussion Forum
BARD innovations
supported with an educational grant from
C. R. BARD
Moderator:
EricDucasse
Discussant:
BartDolmatch
-
Introduction
-
Single center patency rates and clinical results of the VENOVO® venous stent in complicated cases
MichaelLichtenberg
-
The role of COVERA™ vascular covered stent in the management of dysfunctioning AV access
BartDolmatch
-
Expanding the treatment options of atherosclerotic lesions in femoral arteries with COVERA PLUS™
MassimilianoDi Primio
-
A look at focused force in calcified lesions
RalfLanghoff
-
Discussion and conclusion
Thursday, February 1st:
-
,
Room 4 - Discussion Forum
VIVA@LINC: Strategies on the frontline – case-based examinations of contemporary carotid challenges
Moderator:
ChrisMetzger
Discussant:
GaryAnsel,
DanielaBranzan,
WilliamGray,
TonyDas
What did I learn from my last case of hyperperfusion syndrome?
GaryAnsel
Management of coincidental disease when treating the carotid bifurcation
DanielaBranzan
Technical tips for transcervical approach to carotid stenting (TCAR)
WilliamGray
Management of carotid in-stent restenosis
TonyDas
This is a case-based session focusing on what we like best ... real cases with challenges and complications that make the experts sweat. In this amphitheater setting, audience participation is encouraged and step-by-step case management is featured and discussed. This round room setting is dedicated to controversial or interactive talk-show-like sessions.
Cookie settings
We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operation of the website and to manage our corporate commercial objectives, as well as other cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for the display of personalised content. With the exception of strictly necessary cookies, your are free to decide which categories you would like to permit. Please note that depending on the settings you choose, the full functionality of the website may no longer be available. Further information can be found in our privacy statement and cookie policy.
For more infos on the cookies we use and how you can manage them, please visit our cookie policy.